Intravenous immunoglobulin (IVIg) or IVIg-treated macrophages reduce DSS-induced colitis by inducing macrophage IL-10 production. [electronic resource]
Producer: 20200527Description: 1251-1268 p. digitalISSN:- 1521-4141
- Adoptive Transfer
- Animals
- Cell Differentiation
- Cells, Cultured
- Colitis -- chemically induced
- Colon -- metabolism
- Dextran Sulfate
- Disease Models, Animal
- Humans
- Immunoglobulins, Intravenous -- therapeutic use
- Inflammation Mediators -- metabolism
- Inflammatory Bowel Diseases -- drug therapy
- Interleukin-10 -- genetics
- Macrophages -- drug effects
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C57BL
- Mice, Knockout
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.